Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever

July 23, 2016 updated by: Fu Xueying, Beijing Friendship Hospital
The study will use several laboratory diagnoses in the diagnosis of patients with fever,to find out which will be more helpful for making an accurate diagnosis in the early period of Tickborne Diseases.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Tickborne Diseases(TBDs) spread throughout many countries and regions. In recent years, the incidence has a tendency to rise continuously. The clinical symptoms and laboratory features of tick-borne diseases are always of no specific, and the diagnostic methods available, such as observing the pathogen after cultivation or by the method of Gimenez、serological tests for antibody always can't make a timely diagnosis, especially in the early period of the disease. The development of polymerase chain reaction(PCR) has been applied for pathogen detection, and showed high sensitivity and specificity,and may contribute to early diagnose,but no standardized method of PCR has been as yet proposed. This study mean to explore several laboratory diagnoses to find out which will be more helpful for making an accurate diagnosis in the early period of TBDs.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: wenjie Qi, archiater
  • Phone Number: 010-63138749
  • Email: qwj02@126.com

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100050
        • Recruiting
        • Organization Name Beijing Friendship Hospital,Capital Medical University
        • Contact:
          • wenjie Qi, archiater
          • Phone Number: 13601318203
          • Email: qwj02@126.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all the people who have fever with unknown origin

Description

Inclusion Criteria:

  • patients have fever more than one week
  • temperature is higher than 38℃ Celsius degree
  • full of physical examination and laboratory examination have been carried out after one week,but still cannot make a definite diagnosis

Exclusion Criteria:

  • fever for non-infectious diseases such as rheumatic autoimmune disease or with tumor
  • we find that the patient selected does not meet the selection criteria within the observation period
  • patients leave with automatic discharge

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Fever,none definite diagnosis
Those who have fever,but the doctor can not make definite diagnoses with the diagnostic methods available.
explore several laboratory diagnostic methods to find out which will be more helpful for making an accurate diagnosis in the early period of TBDs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evidence of immunoglobulin M and immunoglobulin G titres in acute and convalescent serum or a fragment of the specific gene from patients' whole blood
Time Frame: within the first 14 days in hospital
within the first 14 days in hospital

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the sensitivity and specificity of the laboratory diagnostic methods Related to the reserach
Time Frame: up to three years
compare the sensitivity and specificity of all the laboratory diagnostic methods, using statistical methods, to find out the most helpful one for making an accurate diagnosis in the early period of TBDs.
up to three years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: wenjie Qi, archiater, Beijing Friendship Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Anticipated)

September 1, 2018

Study Completion (Anticipated)

September 1, 2018

Study Registration Dates

First Submitted

November 28, 2015

First Submitted That Met QC Criteria

November 28, 2015

First Posted (Estimate)

December 1, 2015

Study Record Updates

Last Update Posted (Estimate)

July 26, 2016

Last Update Submitted That Met QC Criteria

July 23, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Z151100004015029

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fever of Unknown Origin

Clinical Trials on diagnostic methods

3
Subscribe